Target intelligence / Profile preview

Diuretic activity

Molecular classification
Other
01

Overview

Diuretic activity refers to the physiological process of increasing urine production and the subsequent excretion of water and electrolytes from the body. It is important to note that 'Diuretic activity' is a pharmacological effect or bioactivity rather than a single molecular target. This activity is elicited by various classes of drugs that interact with distinct molecular targets within the kidney, such as the Sodium-potassium-chloride cotransporter 2 (NKCC2), the Sodium-chloride symporter (NCC), Carbonic anhydrase enzymes, and the Mineralocorticoid receptor [4, 7, 12]. By modulating these targets, diuretics interfere with the reabsorption of sodium and other solutes in different segments of the nephron, leading to osmotic water retention in the tubule lumen and increased urine flow [7, 9]. Clinically, diuretic activity is essential for managing conditions characterized by fluid overload, including hypertension, congestive heart failure, and edematous states associated with renal or hepatic disease [4, 7]. The therapeutic use of diuretics requires careful monitoring due to potential safety concerns such as electrolyte imbalances and the activation of compensatory mechanisms like the renin-angiotensin-aldosterone system [4, 12].

Other names
DiuresisNatriuretic activityAquaretic activityUrine productionRenal excretion
02

Mechanism of action

Diuretic activity is achieved through the inhibition of specific ion transporters, symporters, enzymes, or hormone receptors in the renal tubules, which reduces the reabsorption of sodium and water from the filtrate back into the blood, thereby increasing urine output.

03

Biological functions

Regulation of water and salt metabolismMaintenance of homeostasisExcretion of urineSodium and water excretionBlood pressure regulation
04

Disease associations

HypertensionCongestive heart failureKidney disordersEdemaNephrotic syndromeLiver cirrhosis
05

Safety considerations

Electrolyte imbalance (hypokalemia, hyponatremia, hypomagnesemia)DehydrationHypovolemiaHyperuricemiaHyperglycemiaMetabolic alkalosisOtotoxicity (primarily associated with loop diuretics)
06

Interacting drugs

Furosemide

8 more in the full profile.

07

Biomarkers

Urine volumeUrinary sodium concentrationUrinary potassium concentrationUrinary chloride concentrationUrinary osmolalitySerum electrolyte levelsBlood pressure

Beyond the preview

Go deeper on Diuretic activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diuretic activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call